Safety and effectiveness of intravenous iron sucrose versus standard oral iron therapy in pregnant women with moderate anaemia in India

Sadhna Soni; Yashika Sheetal; Renu Sharma; Surbhi Kundal; Khushpreet Kaur

doi:10.18203/2320-1770.ijrcog20232730

Authors

Sadhna Soni Department of Obstetrics and Gynecology, Mata Kaushalya Government Hospital, Patiala, Punjab, India
Yashika Sheetal Department of Obstetrics and Gynecology, Mata Kaushalya Government Hospital, Patiala, Punjab, India
Renu Sharma Department of Obstetrics and Gynecology, Mata Kaushalya Government Hospital, Patiala, Punjab, India
Surbhi Kundal Department of Obstetrics and Gynecology, Mata Kaushalya Government Hospital, Patiala, Punjab, India
Khushpreet Kaur Department of Obstetrics and Gynecology, Mata Kaushalya Government Hospital, Patiala, Punjab, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20232730

Keywords:

Hemoglobin, Iron deficiency anaemia, Microcytic-hypochromic, Peripheral blood film

Abstract

Background: Aim of the study was to diagnose and treat pregnant females with iron deficiency anaemia, to reduce the complications associated with anaemia in pregnancy and to compare the efficacy, safety and side effects of iron sucrose with ferrous sulphate in the treatment of iron deficiency anaemia in pregnancy.

Methods: The subjects for study were enrolled on fulfilling the inclusion and exclusion criteria. After detailed history, examination and investigations of patient the dose of intravenous iron sucrose was calculated by using the following formula: dose of iron: 2.4 x Hb deficit (11-patient’s actual Hb) x body weight in kg + 500. The following investigations were done on day 1: (a) complete blood count (CBC)- Hb, MCV, MCH, MCHC and PCV; (b) urine examination. Patients was randomly allocated into two groups. Group-A: oral group- containing 150 pregnant females. Group-B: intravenous group- containing 150 pregnant females.

Results: Majority of women (48%) were from lower middle class and lower class (30%). Only 5.3% were from higher socioeconomic class (p value 0.0001). Maximum women (60%) were primigravida and 40% were multigravida. which indicates that most ladies enter pregnancy with poor iron reserves. Improvement in the mean haemoglobin levels after 4 weeks of treatment was statistically significant in both the groups (p value 0.0001). Similarly rise in the mean PCV levels after 4 weeks of the treatment was significantly associated in both the groups (p value 0.0001). There was slight rise in the mean MCV and MCH after 4 weeks. Peripheral blood film had changed from microcytic hypochromic to normocytic normochromic after 4 weeks of the treatment in both the group (p value 0.004). Presence of side effects with the oral and parenteral treatment were 81.3% and 12% respectively (p value 0.0001).

Conclusions: From our study, it can be concluded that intravenous iron sucrose has lesser side effects along with better absorption.

Metrics

Metrics Loading ...

References

Arias F, Bhide AG, Arulkumaran S, Damania K, Daftary SN, eds. Arias’ Practical Guide to High Risk Pregnancy and Delivery, 5th edn. Elsevier India; 2019.

Pitale DL. Effectiveness of intravenous iron sucrose over oral iron therapy for anaemia in pregnancy. Int J Reprod Contracept Obstet Gynecol. 2018;1908-11.

Konar H. DC Dutta’s textbook of Obstetrics. 9th edn. Jaypee Brothers Medical Publishers (P) Ltd.; 2018:250.

Thobbi VA, Bijapur ZNM. A comparative study of efficacy, safety and compliance of oral iron versus intravenous iron sucrose in treatment of iron deficiency anaemia of pregnancy. Int J Reprod Contracept Obstet Gynecol. 2020;9:3852-7.

Maiti GD, Gupta S, Singh J. Anaemia in pregnancy: prevalence and treatment response to various modalities: a prospective study. Int J Reprod Contracept Obstet Gynecol. 2020;9:3784-9.

Haider AB. Anaemia, prenatal iron use, and risk of adverse pregnancy outcomes: systematic review and meta analysis. BMJ. 2013;346:f3443.

World Health Organization. Iron deficiency anaemia: assessment, prevention and control. A guide for programme managers. 2001. Available from: https://www.who.int/publications/m/item/iron-children-6to23--archived-iron-deficiency-anaemia-assessment-prevention-and-control. Accessed on 2 March 2023.

Nimbalkar PB, Patel JN, Thakor N. Evaluation of intravenous iron sucrose therapy for management of moderate to severe anaemia in pregnancy. Int J Reprod Contracept Obstet Gynecol. 2017;6:5272-6.

Mala YM. Case discussion in Obstetrics and Gynecology. 2nd edn. Jaypee Brothers Medical Publishers; 2019.

WHO. Haemoglobin concentration for the diagnosis of anemia in pregnancy.

Rudra S, Chandna A, Nath J. Comparison of intravenous iron sucrose with oral iron in pregnant women with iron deficiency anaemia. Int J Reprod Contracept Obstet Gynecol. 2016;5:747-51.

Neeru S, Nair NS, Rai L. Iron sucrose versus oral iron therapy in pregnant anaemia. Indian J Community Med. 2012;37:214-8.

Tandon A, Gupta V, Chaudhari P, Kumari N. Comparison between intravenous iron sucrose versus oral iron therapy in pregnant women with nutritional anaemia: a prospective study. Int J Reprod Contracept Obstet Gyneco.l 2016;5:2278-81.

Prajapati SM, Patel MK. A study of efficacy of oral iron and intravenous iron sucrose in the treatment of moderate anaemia in pregnancy. Int J Reprod Contracept Obstet Gynecol. 2019;8:2221-5.

Rudra S, Chandna A, Nath J. Comparison of intravenous iron sucrose with oral iron in pregnant women with iron deficiency anaemia. Int J Reprod Contracept Obstet Gynecol. 2016;5:747-51.

Garg A, Agarwal M, Shankar U, Shetty S. Comparative study of oral iron and intravenous iron sucrose for the treatment of iron deficiency anaemia in pregnancy. Int J Reprod Contracept Obstet Gynecol. 2017;6:172-5.

Prajapati SM, Patel MK. A study of efficacy of oral iron and intravenous iron sucrose in the treatment of moderate anaemia in pregnancy. Int J Reprod Contracept Obstet Gynecol. 2019;8:2221-5.

Gupta S, Gupta R. A comparative study of oral versus intravenous iron in the treatment of moderately anaemiaic pregnant women. Int J Reprod Contracept Obstetrics Gynecol. 2020;9:3972-6.

Khan Q, Bhingare PE, Gadappa SN, Madane LA. Comparative study of oral iron therapy and intravenous iron therapy in the iron deficient pregnant women. Int J Gynecol. 2017;3(1):47-9.

Rai S. Parenteral iron prophylaxis: a convenient alternative for antenatal women who do not consume oral iron. Int J Reprod Contracept Obstet Gynecol. 2017;6(9):3832-7.

Nimbalkar PB, Patel JN, Thakor N. Evaluation of intravenous iron sucrose therapy for management of moderate to severe anaemia in pregnancy. Int J Reprod Contracept Obstet Gynecol. 2017;6:5272-6.

Suganya G, Vimala D. A comparative study of oral iron and intravenous iron in iron deficient antenatal mothers. Int J Reprod Contracept Obstet Gynecol. 2018;7:1848-51.